UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052545
Receipt number R000059946
Scientific Title Investigation of changes in surface temperature, muscle, and blood flow in the face as a result of food ingestion.
Date of disclosure of the study information 2023/10/20
Last modified on 2024/04/22 08:57:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of changes in surface temperature, muscle, and blood flow in the face as a result of food ingestion.

Acronym

Investigation of changes in surface temperature, muscle, and blood flow in the face as a result of food ingestion.

Scientific Title

Investigation of changes in surface temperature, muscle, and blood flow in the face as a result of food ingestion.

Scientific Title:Acronym

Investigation of changes in surface temperature, muscle, and blood flow in the face as a result of food ingestion.

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of changes in surface temperature, muscle, and blood flow in the face as a result of food ingestion.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

*Facial surface temperature
*Myogram
*Hemoglobin concentration

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Food

Interventions/Control_1

Test food

Interventions/Control_2

No intake

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

69 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Those who can eat the test foods ( preference)
(2) Those who have no dental symptoms and are not under dental treatment (periodic dental cleanings are acceptable)
(3) Those who have received sufficient explanation of the purpose and content of the study, have the ability to consent, have voluntarily volunteered to participate with a good understanding, and have agreed to participate in this study in writing

Key exclusion criteria

(1) Those who have any symptoms that may affect test food intake
(2) Those who may develop allergies related to the study
(3) Those who are judged by the study representative to be inappropriate to participate in this study

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Kazuto
Middle name
Last name Okabayashi

Organization

Lotte Co., Ltd.

Division name

Central Laboratory, Kamukoto Research Department

Zip code

336-8601

Address

1-1, Numakage-3chome, Minami-ku, Saitama

TEL

048-837-0744

Email

okabayashi_kazuto@lotte.co.jp


Public contact

Name of contact person

1st name Kazuto
Middle name
Last name Okabayashi

Organization

Lotte Co., Ltd.

Division name

Central Laboratory, Kamukoto Research Department

Zip code

336-8601

Address

1-1, Numakage-3chome, Minami-ku, Saitama

TEL

048-837-0744

Homepage URL


Email

okabayashi_kazuto@lotte.co.jp


Sponsor or person

Institute

Lotte Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Lotte Co., Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic

Address

6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan

Tel

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

12

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 07 Month 14 Day

Date of IRB

2023 Year 10 Month 12 Day

Anticipated trial start date

2023 Year 10 Month 20 Day

Last follow-up date

2023 Year 11 Month 29 Day

Date of closure to data entry

2023 Year 11 Month 29 Day

Date trial data considered complete

2023 Year 12 Month 10 Day

Date analysis concluded

2023 Year 12 Month 12 Day


Other

Other related information



Management information

Registered date

2023 Year 10 Month 19 Day

Last modified on

2024 Year 04 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059946


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name